301 related articles for article (PubMed ID: 23117949)
21. The myotonic dystrophies: diagnosis and management.
Turner C; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):358-67. PubMed ID: 20176601
[TBL] [Abstract][Full Text] [Related]
22. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
23. Myotonic dystrophy types 1 and 2.
Ashizawa T; Sarkar PS
Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
[TBL] [Abstract][Full Text] [Related]
24. Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.
Meola G; Biasini F; Valaperta R; Costa E; Cardani R
J Neurol; 2017 Aug; 264(8):1705-1714. PubMed ID: 28550479
[TBL] [Abstract][Full Text] [Related]
25. Myotonic dystrophy.
Jozefowicz RF; Griggs RC
Neurol Clin; 1988 Aug; 6(3):455-72. PubMed ID: 3065594
[TBL] [Abstract][Full Text] [Related]
26. Myotonic dystrophy with no trinucleotide repeat expansion.
Thornton CA; Griggs RC; Moxley RT
Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879
[TBL] [Abstract][Full Text] [Related]
27. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
[TBL] [Abstract][Full Text] [Related]
28. Perspectives on gene therapy in myotonic dystrophy type 1.
Magaña JJ; Cisneros B
J Neurosci Res; 2011 Mar; 89(3):275-85. PubMed ID: 21259315
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
Tieleman AA; van Vliet J; Jansen JB; van der Kooi AJ; Borm GF; van Engelen BG
Neuromuscul Disord; 2008 Aug; 18(8):646-9. PubMed ID: 18602828
[TBL] [Abstract][Full Text] [Related]
30. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
31. Progressive conduction disturbance in myotonic dystrophy.
Palazzolo J; Trucco E; Arce M; Riera AR; Femenía F
Cardiol J; 2011; 18(3):322-5. PubMed ID: 21660927
[TBL] [Abstract][Full Text] [Related]
32. Myotonic dystrophy: diagnosis, management and new therapies.
Turner C; Hilton-Jones D
Curr Opin Neurol; 2014 Oct; 27(5):599-606. PubMed ID: 25121518
[TBL] [Abstract][Full Text] [Related]
33. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
[TBL] [Abstract][Full Text] [Related]
34. [Myotonic dystrophy].
Nanba E
Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
[TBL] [Abstract][Full Text] [Related]
35. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
36. Carrell-Krusen Symposium Invited Lecture-1997. Myotonic disorders in childhood: diagnosis and treatment.
Moxley RT
J Child Neurol; 1997 Feb; 12(2):116-29. PubMed ID: 9075021
[TBL] [Abstract][Full Text] [Related]
37. Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in
Souidi A; Zmojdzian M; Jagla K
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567354
[TBL] [Abstract][Full Text] [Related]
38. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
Kaliman P; Llagostera E
Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
[TBL] [Abstract][Full Text] [Related]
39. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2.
Kornblum C; Reul J; Kress W; Grothe C; Amanatidis N; Klockgether T; Schröder R
J Neurol; 2004 Jun; 251(6):710-4. PubMed ID: 15311347
[TBL] [Abstract][Full Text] [Related]
40. Contrasts in clinical presentation and genetic transmission of myotonic dystrophy.
Reifer H; Sobel E
J Am Podiatr Med Assoc; 1998 Jul; 88(7):313-22. PubMed ID: 9680767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
